GIULIANI, EUGENIA
 Distribuzione geografica
Continente #
NA - Nord America 465
EU - Europa 208
AS - Asia 131
AF - Africa 7
SA - Sud America 3
Totale 814
Nazione #
US - Stati Uniti d'America 463
IT - Italia 134
SG - Singapore 57
IN - India 35
CN - Cina 28
DE - Germania 24
SE - Svezia 17
BG - Bulgaria 11
TG - Togo 5
BE - Belgio 4
HK - Hong Kong 4
IE - Irlanda 4
FI - Finlandia 3
ID - Indonesia 3
CA - Canada 2
DK - Danimarca 2
GB - Regno Unito 2
IR - Iran 2
AR - Argentina 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
FR - Francia 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
NL - Olanda 1
PT - Portogallo 1
RO - Romania 1
UA - Ucraina 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 814
Città #
Rome 64
Chandler 57
Fairfield 48
Singapore 43
Woodbridge 38
Ashburn 31
Seattle 26
Cambridge 24
Houston 24
Wilmington 22
Princeton 18
Grafing 17
Beijing 15
New York 14
Des Moines 13
Santa Clara 13
Sofia 11
Pune 10
Redmond 10
Fremont 8
San Paolo di Civitate 7
Dearborn 5
Lomé 5
Plano 5
Andover 4
Ann Arbor 4
Bell Gardens 4
Boardman 4
Brussels 4
Bühl 4
Dublin 4
Hong Kong 4
Lawrence 4
Millbury 4
San Diego 4
Boston 3
Helsinki 3
Jakarta 3
Kunming 3
Padova 3
Bracciano 2
Florence 2
Frederiksberg 2
Jinan 2
London 2
Nanjing 2
Norwalk 2
Phoenix 2
Alora 1
Antrodoco 1
Aversa 1
Bishkek 1
Buffalo 1
Chengdu 1
Clifton 1
Falkenstein 1
Federal 1
Guangzhou 1
Hefei 1
Ho Chi Minh City 1
Hyderabad 1
Kashan 1
Langfang 1
Lauria 1
Los Angeles 1
Marino 1
Ottawa 1
Quito 1
Reggio Emilia 1
Riga 1
Saint Charles 1
Santiago 1
Shenyang 1
Silverton 1
Tivoli 1
Toronto 1
Vietri Sul Mare 1
Wuhan 1
Totale 633
Nome #
NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest 131
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response 107
Notch signaling activation as a hallmark for triple-negative breast cancer subtype 103
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. 71
Vaccine-preventable anal infections by human papillomavirus among HIV-infected men who have sex with men 57
Targeting the ER/UPR signalling in Notch3-overexpressing T-cell acute lymphoblastic leukemia. 54
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response 54
Cytotoxic activity of Juglone against Notch3-overexpressing T-cell acute lymphoblastic leukemia: targeting the ER/UPR signaling 47
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application 45
Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment 43
Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer 42
Anal and oral human papillomavirus infection in men who have sex with men: implications for risk-targeted vaccination 39
Potential targeted therapy for T-cell acute lymphoblastic leukemia: perturbing ER/UPR signaling via Notch3 down-regulation 37
Role of Notch3 in sustaining UPR signaling in Notch3-overexpressing T-cell acute lymphoblastic leukemia. 32
Totale 862
Categoria #
all - tutte 2.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 0 0 13 37 20 15 15 12 5
2020/2021137 9 4 3 21 18 14 6 5 11 40 6 0
2021/2022107 5 6 2 6 20 3 0 18 9 10 13 15
2022/2023167 34 32 11 13 18 34 2 4 6 0 8 5
2023/2024130 5 7 2 3 18 45 3 10 0 20 8 9
2024/202585 4 26 9 17 20 9 0 0 0 0 0 0
Totale 862